Abstract:Aminoglycosides are important broad-spectrum antibiotics used in the therapy of many microbial infections. As the bacterial resistance to antibiotic therapy is appearing as an increasingly significant threat to public health, the development of aminoglycoside antibiotics with extended antibacterial spectrum and potency, devoid of nephro- and ototoxicity, and evading the resistance process returns to the focus of researchers. In this review, various developments brought to the aminoglycoside family of antibiotics effective against resistant bacteria have been described, focused on chemical modifications, drug-modifying enzyme inhibitors, and conformationally constrained analogs, as well as related antibacterial compounds, with the hope to provide information useful in rational design of novel antibiotics addressing bacterial resistance, and paving the way for new perspectives in antimicrobial therapy. Keywords: Aminoglycoside antibiotics, drug-modifying enzymes, bacterial resistance, inhibitor, antimicrobial activity, Aminoglycoside, broad-spectrum antibiotics, antimicrobial therapy, Gram-negative, Gram-positive, aminocyclitol, glycosidic linkage, 2-deoxystreptamine, streptidine ring, spectinomycin, Mycobacterium tuberculosis, neomycin, pa-ramomycin, kanamycins, tobramycin, gentamicins, semi-synthetic derivatives amikamycin, dibekacin, sisomicin, netilmicin, Ototoxicity, 16S rRNA, phosphotransferases, adenyltransferases, acetyltrans-ferases, Anti-APH(3')s, Aminoglycoside 3'-phosphotransferases, Gram-negative APH(3'), neomycin B, anti-anthrax drugs, Anti-APH(2'')/AAC(6'), methicillin-resistant Staphylococcus aureus, O-acetyltransfer, N-acetyltransfer, Arbekacin, aminoglycoside-modifying, 5-deoxy-5-episubstituted arbekacin derivatives, 5-deoxy-5-epiamino-ABK, aminoglycoside-modifying enzyme, resistance nodulation division, tetraazidoneamine, ribostamycin and pyranmycin, pSF815 plasmid, acetyl coenzyme A, synthetic AAC(6') in-hibitors, pyrophosphate group, structure-activity relationships, ANT (2'') Inhibitors, aminoglycoside-resistant bacteria, APH Inhibitors, nucleophilic amino acid side chain, protein kinases, acetyltransferases, nucleo-tidyltransferases, sulfotransferases, X-ray crystallography, paromomycin, Dimeric Derivatives, hydroxyamine motif, Hoog-steen face, neamine dimers, vancomycin-resistant enterococci, fluoroquinolone- ciprofloxacin, DNA gyrase, topoisomerase, Cipro-NeoB hybrids, C16 or C20 fatty acid, multidrug resistant, 3,5-diamino-piperidinyl triazines, Neamine-derived pseudodisaccharides, Non-Carbohydrate Inhibitors of AGMEs, bovine antimicrobial peptide indolicidin

Design, Synthesis, and Bioassay of 5-Epi-aminoglycosides.

Nosiheptide Analogues As Potential Antibacterial Agents Via Dehydroalanine Region Modifications: Semi-synthesis, Antimicrobial Activity and Molecular Docking Study.

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, Synthesis, and Bioassay of 2 '-Modified Kanamycin A

Modifications Of Aminogocoside Antibiotics Targeting Rna

Synthesis and biological evaluation of neamine analogues for RNA binding

Design, Synthesis and Activity Evaluation Against Drug‐Resistant Bacteria of 6'‐Amidine Modified Aminoglycoside Derivatives

Synthesis and Evaluation of Novel Neamine-Nucleoside Conjugates as Potential Antibiotic Targets for Escherichia coli 16S Ribosomal RNA

Modifications of Aminoglycoside Antibiotics Targeting RNA

Development of Aminoglycoside Antibiotics Effective Against Resistant Bacterial Strains

Synthesis and biological evaluation of novel aminoguanidine derivatives as potential antibacterial agents

Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.

Synthesis Of Neamine-Derived Pseudodisaccharides By Stereo- And Regio-Selective Functional Group Transformations

Design and Synthesis of Sulfanilamide Aminophosphonates as Novel Antibacterial Agents towards Escherichia coli

Discovery of Unique Bis-Substituted Aromatic Amide Derivatives as Novel Highly Potent Antibiotics for Combating Methicillin-Resistant Staphylococcus aureus (MRSA)

Aminoglycoside Mimetics As Small-Molecule Drugs Targeting RNA

Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria

Aminoglycoside‐Based Biomaterials: From Material Design to Antibacterial and Gene Delivery Applications

Structural analysis of neomycin B and kanamycin A binding Aminoglycosides Modifying Enzymes (AME) and bacterial ribosomal RNA

Structure-based Discovery of Novel Antibacterials

Parallel Pathways in the Biosynthesis of Aminoglycoside Antibiotics